(Adnkronos) - “Rispetto al passato esistono proposte terapeutiche capaci di curare anche la psoriasi severa, ma molte persone non lo sanno. La nostra associazione ha il dovere di informare i pazienti”. Così Valeria Corazza, presidente Associazione psoriasici italiani amici Fondazione Corazza - ApiaFCo, in occasione della conferenza stampa organizzata da Bristol Myers Squibb per annunciare il via libera da parte di Aifa alla rimborsabilità di deucravacitinib per il trattamento della psoriasi da moderata a severa.
Category
🗞
NewsTranscript
00:00Today, those who treat us rely on a lot of therapeutic proposals that can treat both those with two
00:14macular defects, but above all those with 250,000 patients who instead suffer from severe psoriasis
00:20and can also have their body covered 90% or have it above all in the face, in the hands,
00:26which are, let's say, our ticket to presentation. So I would say that today, as it is today,
00:33being able to have these choices is not a small thing, but there is also a very big problem,
00:37which is a lack of information. Our association must, in the most absolute way,
00:43do a certain job, which is to inform patients of what is happening,
00:48because many people do not know. They continue, just in case, not to be cured, to be afraid of
00:55side effects, and instead they cannot, let's say, if not with help and with a little
01:02being on the road, go to the right place. So in the right place and with the right people.
01:08Today a new drug has come out. For us it is clearly a very important thing, in fact, first
01:15because it means that the interest in our pathology exists. Counting on research is
01:21a very important thing for us, to see that research works much more, but the information,
01:28which is what the association must do, is also an absolutely important piece. Believe me,
01:34there are those who do not know where to go, there are those who do not know the beautiful things that
01:39are done for this pathology, which when it is in severe form is a devastating matter.